Last updated 2026-06-18
- Went public (THXBY), Dec 2005
- Raised $9.2M PIPE, Jan 2026
- Raised $5M PIPE, Oct 2023
Total raised
$63.8M
Last: PIPE 2026-01
Stage
Public
Founded
2004
Headcount
4
HQ
Giv'atayim, Israel
Sector
Health Tech & Life Sciences
About
SciSparc is a specialty clinical-stage pharmaceutical company focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company is currently engaged in drug development programs based on THC and/or non-psychoactive cannabidiol (CBD), including SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimers disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy.
Funding history · 9 rounds · $63.8M total
2005-12
Public Offering
$10.4M
2017-03
Public Offering
$12.0M
2019-04
PIPE
$2.3M
2019-12
PIPE
$1.3M
2020-11
Public Offering
$4.2M
2021-03
PIPE
$8.2M
2022-06
PIPE
$10.0M
2023-10
PIPE
$5.0M
2026-01
PIPE
$9.2M
Q&A
- What is SciSparc's primary focus as a pharmaceutical company?
- SciSparc is a clinical-stage pharmaceutical company specializing in creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals.
- What drug development programs is SciSparc currently engaged in?
- SciSparc is engaged in drug development programs based on THC and/or non-psychoactive cannabidiol (CBD), including SCI-110 for Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for pain; and SCI-210 for autism spectrum disorder and epilepsy.
- When did SciSparc complete its most recent funding round?
- SciSparc completed a PIPE funding round in January 2026, raising $9,180,000.
- What was SciSparc's most recent acquisition?
- SciSparc acquired Neurothera Labs in October 2025.
- What was SciSparc's most recent public offering?
- SciSparc had a public offering in August 2023, raising $1,300,000 on NASDAQ under the ticker SPRC.
- When was SciSparc founded?
- SciSparc was founded in August 2004.
- What is the current status of SciSparc?
- SciSparc is a public company, having gone public on NASDAQ in March 2017.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
chronic-painpain-reliefcns-disordersdrug-developmentapneapharmaceuticalsautismchronic-diseasealzheimers-diseaseinfectious-diseasemental-healthcancermedical-cannabisimmunotherapyepilepsytherapeuticsdrug-delivery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | scisparc.com/ |
|---|---|
| linkedin.com/company/71540465 | |
| facebook.com/SciSparc |
Identifiers & details
| Legal name | SciSparc |
|---|---|
| Former names | Therapix Biosciences, Nasvax |
| Founded | 2004-8 |
| Employees (exact) | 4 |
| Market cap | $4.5M |
| Status reason | Public on NASDAQ on Mar 2017; |
Acquisitions & public offerings
| Acquired | Date | Amount |
|---|---|---|
| 2025-10 | ||
| 2014-10 | ||
| 2014-08 | $2.3M |
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| 2023-08 | SPRC | $1.3M | ||
| 2021-12 | SPRC | |||
| 2021-08 | ||||
| 2020-11 | TRPXY | $4.2M | ||
| 2020-07 | TRPXY | |||
| 2018-08 | ||||
| 2017-03 | SPRC | $12.0M | ||
| 2005-12 | THXBY | $10.4M |